---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-011142"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-13T23:49:29.045900+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Iradimed shareholders elect all five director nominees, approve equity plan and charter amendment

## Summary
- Roger Susi, Monty Allen, Anthony Vuoto, Hilda Scharen-Guivel, James Hawkins elected to board (vote ranges: 7.9M-10.9M for).
- Ratified RSM US LLP as auditor for FY2023 (11,617,623 for, 8,816 against).
- Advisory say-on-pay approved (10,782,715 for, 133,595 against).
- Approved 2023 Equity Incentive Plan (8,665,347 for, 2,251,481 against).
- Approved charter amendment limiting officer liability (10,139,697 for, 779,087 against).

## SEC filing metadata
- accession: 0001558370-23-011142
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/irmd-20230615x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-011142
- JSON: https://secwatch.observer/filing/0001558370-23-011142.json
- Plain text: https://secwatch.observer/filing/0001558370-23-011142.txt

## Key facts
- Shareholder Votes
  IRADIMED CORP shareholders approved Advisory vote on the frequency of future advisory votes on executive compensation at the 2023-06-15 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Stockholders voted, on an advisory basis, on the frequency of future advisory votes on executive compensation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm
- Shareholder Votes
  IRADIMED CORP shareholders approved Advisory resolution on the compensation of Iradimed's named executive officers at the 2023-06-15 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Stockholders approved an advisory resolution on the compensation of Iradimed's named executive officers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm
- Shareholder Votes
  IRADIMED CORP shareholders approved Election of Directors at the 2023-06-15 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Stockholders elected each of Roger Susi, Monty Allen, Anthony Vuoto, Hilda Scharen-Guivel and James Hawkins to Iradimed's Board of Directors, each to hold office until a succeeding annual meeting of stockholders or until such director's successor shall have been duly elected and qualified (or, if earlier, such director's removal or resignation from our Board), as set forth below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm
- Shareholder Votes
  IRADIMED CORP shareholders approved Amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company at the 2023-06-15 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Stockholders approved an amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm
- Shareholder Votes
  IRADIMED CORP shareholders approved Approval of the Iradimed Corporation 2023 Equity Incentive Plan at the 2023-06-15 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Stockholders approved the Iradimed Corporation 2023 Equity Incentive Plan.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm
- Shareholder Votes
  IRADIMED CORP shareholders approved Ratification of the selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2023 at the 2023-06-15 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Stockholders ratified the selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2023, as set forth below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.